BIO RAD laboratories INC. – liquichek tumor regeants
Closed Pre-Solicitation Posted
- Solicitation number
- 26-005107
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health Clinical Center intends to award a sole-source firm-fixed-price contract to Bio-Rad Laboratories for Liquichek Tumor Reagents, a testing control product for cardiac, cancer, and infectious disease markers, with a capability-statement response deadline of May 24, 2026. This acquisition is conducted under FAR 13.106-1(b)(1) (single-source procurement under simplified acquisition procedures) because Bio-Rad Laboratories is the sole manufacturer of the product; substitution is not permissible without revalidation and regulatory approval that could delay treatment and compromise patient care.
Performance occurs at the NIH Clinical Center in Bethesda, Maryland, supporting the Department of Laboratory Medicine Immunoassay laboratory. The requirement serves 35 research protocols across multiple Institutes; long-term protocol consistency demands identical testing methodologies and instrumentation to maintain laboratory-value stability over multi-year studies. This pre-solicitation notice is for informational purposes only and does not constitute a request for quotations; no competitive solicitation will be issued. Interested parties may submit capability statements demonstrating ability to meet Government requirements, though the Government reserves the right to solicit only from the identified source.
Notice text
Place of Performance:
National Institutes of Health
Clinical Center
Bethesda, MD 20892
POTS: 26-005107
Description
This notice is issued for informational purposes only and does not constitute a request for quotations. A solicitation will not be issued, and quotations will not be requested.
The National Institutes of Health (NIH), Clinical Center, intends to award a sole source firm-fixed-price contract to Bio-Rad Laboratories for the procurement of Liquichek Tumor Regeants.
The requirement consists of testing controls for cardiac, cancer and infectious disease markers for Liquichek Tumor Regeants, which provide consistent, high-quality results for clinical center patients within the Department of Laboratory Medicine (DLM) Immunoassay laboratory.
Background
The Department of Laboratory Medicine (DLM) Immunoassay laboratory currently provides services for 35 protocols across several Institutes, and they all require highly accurate and rapid results. In addition, some research protocols extend over several years, it is very important for laboratory values to remain consistent over time through the same testing methodologies and similar instrumentation.
Rationale:
Bio-Rad Laboratories is the sole manufacturer of Liquichek Tumor Regeants. Substitution is not permissible without revalidation and regulatory approval, which could delay treatment and pose risks to patient care
Authority
This acquisition is being conducted in accordance with:
FAR 13.106-1(b)(1) – Soliciting from a Single Source
Under this authority, the Contracting Officer may solicit from a single source when it is determined that only one source is reasonably available to meet the Government’s requirements.
Acquisitions conducted under FAR Part 13 – Simplified Acquisition Procedures are exempt from the competition requirements of FAR Part 6.
Responses
This is not a request for quotations. However, interested parties may submit a capability statement demonstrating their ability to meet the Government’s requirement.
Responses must include:
- Company name and address
- Technical capability
- Proof of OEM authorization
- Relevant past performance
The Government will evaluate capability statements received in response to this notice. The determination not to compete this requirement is solely within the discretion of the Government.
Submission Instructions
Responses referencing POTS: 26-005107 must be submitted electronically no later than May 24, 2026, at 8:00 AM EST to:
Gregory Noland
Hospital and Laboratory Support Division
Office of Acquisitions and Logistics Management
National Institutes of Health
Email: gregory.noland@nih.gov
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity